The FDA has finalized its recommendations for getting AI-equipped medical devices approved. 

A large venture capital firm focused on supporting early-stage healthtech companies has a tip for AI startups targeting the healthcare sector.

After announcing it would place time limits on reimbursement for the time a patient is under anesthesia, Anthem Blue Cross Blue Shield has now denied it ever intended to make the change. 

The NYPD is offering a $10,000 award for “information leading to an arrest and conviction.” No arrests have been made and the killer has yet to be identified. 

Brian Thompson, 50, was walking in Midtown Manhattan toward the New York Hilton Hotel, where he was expected to attend his company’s annual investor conference. He was shot by an unknown gunman who fled the scene. 

Federal AI guardrails are taking shape.

Given the rapid proliferation of AI-equipped medical devices across U.S. healthcare, unintended effects should surprise no one. 

FDA commissioner Robert Califf recently suggested the agency may need to double its workforce. And that’s just to oversee AI.